We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
(-8.2%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$934K |
| 2 |
MASI
Masimo
MASI
|
+$931K |
| 3 |
Palladyne AI
PDYN
|
+$929K |
| 4 |
Equity Lifestyle Properties
ELS
|
+$926K |
| 5 |
BorgWarner
BWA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlyle Group
CG
|
+$962K |
| 2 |
GeneDx Holdings
WGS
|
+$933K |
| 3 |
Viasat
VSAT
|
+$852K |
| 4 |
INFA
Informatica
INFA
|
+$807K |
| 5 |
Amgen
AMGN
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.61% |
| 2 | Technology | 17.16% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 11.59% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
TransUnion
TRU
$14.8B
| – | – |
-4,493
| Closed | -$417K |
|
952
Tyson Foods
TSN
$20.2B
| – | – |
-6,051
| Closed | -$348K |
|
953
Tetra Tech
TTEK
$8.23B
| – | – |
-9,664
| Closed | -$385K |
|
|
TUYA
954
Tuya Inc
TUYA
$1.01B
| – | – |
-77,458
| Closed | -$139K |
|
955
Twist Bioscience
TWST
$5.62B
| – | – |
-9,040
| Closed | -$420K |
|
956
Uber
UBER
$134B
| – | – |
-7,519
| Closed | -$454K |
|
957
Unifirst Corp
UNF
$5.32B
| – | – |
-1,508
| Closed | -$258K |
|
958
US Foods
USFD
$21.4B
| – | – |
-5,293
| Closed | -$357K |
|
959
United States Lime & Minerals
USLM
$3.18B
| – | – |
-3,154
| Closed | -$419K |
|
960
Vertex
VERX
$1.92B
| – | – |
-3,760
| Closed | -$201K |
|
961
Vista Energy
VIST
$7.75B
| – | – |
-6,099
| Closed | -$330K |
|
|
VRE
962
DELISTED
Veris Residential
VRE
| – | – |
-25,433
| Closed | -$423K |
|
963
Varex Imaging
VREX
$460M
| – | – |
-43,232
| Closed | -$631K |
|
964
Varonis Systems
VRNS
$5.25B
| – | – |
-6,459
| Closed | -$287K |
|
965
Verra Mobility
VRRM
$615M
| – | – |
-15,779
| Closed | -$382K |
|
966
VeriSign
VRSN
$25.3B
| – | – |
-2,361
| Closed | -$489K |
|
967
Vertiv
VRT
$112B
| – | – |
-3,924
| Closed | -$446K |
|
|
968
Viasat
VSAT
$9.79B
| – | – |
-100,108
| Closed | -$852K |
|
969
Vesta Real Estate
VTMX
$3.12B
| – | – |
-11,868
| Closed | -$304K |
|
970
Vitesse Energy
VTS
$659M
| – | – |
-10,578
| Closed | -$264K |
|
971
Wayfair
W
$11.1B
| – | – |
-5,055
| Closed | -$224K |
|
972
Westamerica Bancorp
WABC
$1.39B
| – | – |
-5,388
| Closed | -$283K |
|
973
WaFd
WAFD
$2.72B
| – | – |
-12,494
| Closed | -$403K |
|
974
Wendy's
WEN
$1.33B
| – | – |
-22,242
| Closed | -$363K |
|
|
975
GeneDx Holdings
WGS
$1.75B
| – | – |
-12,141
| Closed | -$933K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2025 Portfolio in Review
As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
- EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
- EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
- EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
- EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
- EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
- EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.